• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维脂肪瘢痕内碎裂和延迟的电图预示致心律失常性右心室心肌病的心律失常事件:前瞻性风险分层研究的结果。

Fragmented and delayed electrograms within fibrofatty scar predict arrhythmic events in arrhythmogenic right ventricular cardiomyopathy: results from a prospective risk stratification study.

机构信息

Texas Cardiac Arrhythmia Institute, St David's Medical Center, Austin, Texas 78705, USA.

出版信息

Heart Rhythm. 2012 Aug;9(8):1200-6. doi: 10.1016/j.hrthm.2012.03.057. Epub 2012 Mar 30.

DOI:10.1016/j.hrthm.2012.03.057
PMID:22465294
Abstract

BACKGROUND

Islets of myocytes within fibrofatty scars represent the substrate for reentrant ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy (ARVC). Electroanatomic mapping can reliably identify such areas.

OBJECTIVE

To prospectively test the association between late and fragmented electrograms within scar and arrhythmic events in patients with ARVC.

METHODS

High-density right ventricle electroanatomic mapping was performed in 32 patients with ARVC without history of cardiac arrest or sustained ventricular arrhythmias. Standard definitions of electroanatomic scars and fragmented, isolated, and very late potentials were used. All patients received an implantable cardioverter-defibrillator for the primary prevention of sudden death.

RESULTS

After a mean follow-up of 25 ± 7 months, 12 (38%) patients received appropriate implantable cardioverter-defibrillator shock for sustained ventricular arrhythmias. With the exception of a higher rate of previous syncope (P = .053), patients with arrhythmic events at follow-up did not differ from those who remained free from arrhythmic events in terms of other clinical variables, including cardiac magnetic resonance findings. Electroanatomic scars were present in all patients. The distribution and extent of electroanatomic scars were similar in the 2 groups (38 ± 25 cm(2) vs 33 ± 20 cm(2); P = .51). However, patients with implantable cardioverter-defibrillator shock had a higher prevalence of fragmented electrograms (92% vs 20%; P <.001), of isolated late potentials (75% vs 20%; P = .004), and of very late potentials (67% vs 25%; P = .030). Fragmented electrograms were the only variable independently associated with arrhythmic events at follow-up (hazard ratio 21; P = .015).

CONCLUSION

The presence of fragmented and delayed electrograms within the scar predicts arrhythmic events in ARVC.

摘要

背景

纤维脂肪性瘢痕中的心肌细胞岛是致心律失常性右室心肌病(ARVC)中折返性室性心律失常的基质。电解剖标测可以可靠地识别这些区域。

目的

前瞻性检测 ARVC 患者瘢痕内晚期和碎裂电图与心律失常事件之间的关联。

方法

对 32 例无心脏骤停或持续性室性心律失常史的 ARVC 患者进行高密度右心室电解剖标测。使用电解剖瘢痕和碎裂、孤立和很晚的电位的标准定义。所有患者均因预防猝死而植入了植入式心律转复除颤器。

结果

平均随访 25 ± 7 个月后,12 例(38%)患者因持续性室性心律失常而接受了适当的植入式心律转复除颤器电击。除了先前晕厥的发生率较高(P =.053)外,在随访期间发生心律失常事件的患者与未发生心律失常事件的患者在其他临床变量方面没有差异,包括心脏磁共振检查结果。所有患者均存在电解剖瘢痕。2 组患者的电解剖瘢痕分布和范围相似(38 ± 25 cm² vs 33 ± 20 cm²;P =.51)。然而,植入式心律转复除颤器电击的患者存在碎裂电图的比例更高(92% vs 20%;P <.001)、孤立的晚期电位比例更高(75% vs 20%;P =.004)和很晚的电位比例更高(67% vs 25%;P =.030)。碎裂电图是唯一与随访时心律失常事件独立相关的变量(危险比 21;P =.015)。

结论

瘢痕内存在碎裂和延迟电图预测 ARVC 中的心律失常事件。

相似文献

1
Fragmented and delayed electrograms within fibrofatty scar predict arrhythmic events in arrhythmogenic right ventricular cardiomyopathy: results from a prospective risk stratification study.纤维脂肪瘢痕内碎裂和延迟的电图预示致心律失常性右心室心肌病的心律失常事件:前瞻性风险分层研究的结果。
Heart Rhythm. 2012 Aug;9(8):1200-6. doi: 10.1016/j.hrthm.2012.03.057. Epub 2012 Mar 30.
2
Prognostic value of endocardial voltage mapping in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.心内膜电压标测在致心律失常性右室心肌病/发育不良患者中的预后价值。
Circ Arrhythm Electrophysiol. 2013 Feb;6(1):167-76. doi: 10.1161/CIRCEP.111.974881. Epub 2013 Feb 7.
3
Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.表型表达是致心律失常性右室心肌病发生恶性心律失常事件和心源性猝死的前提条件。
Europace. 2016 Jul;18(7):1086-94. doi: 10.1093/europace/euv205. Epub 2015 Jul 2.
4
Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia.三维电解剖电压标测提高了诊断致心律失常性右室心肌病/发育异常的准确性。
Circulation. 2005 Jun 14;111(23):3042-50. doi: 10.1161/CIRCULATIONAHA.104.486977. Epub 2005 Jun 6.
5
Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.致心律失常性右室心肌病的风险分层
Circulation. 2017 Nov 21;136(21):2068-2082. doi: 10.1161/CIRCULATIONAHA.117.030792.
6
Electrocardiographic predictors of electroanatomic scar size in arrhythmogenic right ventricular cardiomyopathy: implications for arrhythmic risk stratification.心律失常性右室心肌病电解剖瘢痕大小的心电图预测指标:对心律失常风险分层的影响。
J Cardiovasc Electrophysiol. 2013 Dec;24(12):1321-7. doi: 10.1111/jce.12246. Epub 2013 Sep 9.
7
Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment.致心律失常性右室心肌病的终身心律失常风险分层:事件分布及定期重新评估的影响。
Europace. 2018 Jun 1;20(FI1):f20-f29. doi: 10.1093/europace/eux093.
8
Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications.植入式心脏复律除颤器治疗致心律失常性右室发育不良/心肌病:恰当治疗的预测因素、结局及并发症
J Am Heart Assoc. 2017 Jun 6;6(6):e006242. doi: 10.1161/JAHA.117.006242.
9
Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk.致心律失常性右室心肌病:临床过程和心律失常风险的预测因素。
J Am Coll Cardiol. 2016 Dec 13;68(23):2540-2550. doi: 10.1016/j.jacc.2016.09.951.
10
Arrhythmic outcome of arrhythmogenic right ventricular cardiomyopathy patients without implantable defibrillators.致心律失常性右室心肌病患者在未植入除颤器情况下的心律失常结局。
J Cardiovasc Electrophysiol. 2018 Oct;29(10):1396-1402. doi: 10.1111/jce.13668. Epub 2018 Jun 27.

引用本文的文献

1
Arrhythmic Risk Stratification in Patients with Arrhythmogenic Cardiomyopathy.致心律失常性心肌病患者的心律失常风险分层
Diagnostics (Basel). 2025 Apr 30;15(9):1149. doi: 10.3390/diagnostics15091149.
2
The Challenges of Diagnosis and Treatment of Arrhythmogenic Cardiomyopathy: Are We there yet?致心律失常性心肌病的诊断与治疗挑战:我们做到了吗?
Rev Cardiovasc Med. 2022 Aug 15;23(8):283. doi: 10.31083/j.rcm2308283. eCollection 2022 Aug.
3
Catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy and biventricular involvement.
心律失常性右心室心肌病伴双心室受累患者的室性心动过速导管消融。
Europace. 2024 Mar 1;26(3). doi: 10.1093/europace/euae059.
4
Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy.心律失常性右室心肌病的心律失常风险分层。
Europace. 2023 Nov 2;25(11). doi: 10.1093/europace/euad312.
5
Varied Presentation of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C): A Case Series.致心律失常性右室发育不良/心肌病(ARVD/C)的多样表现:病例系列
Cureus. 2023 Jan 17;15(1):e33883. doi: 10.7759/cureus.33883. eCollection 2023 Jan.
6
Epicardial conduction abnormalities in patients with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) and mutation positive healthy family members - A study using electrocardiographic imaging.致心律失常性右心室心肌病(ARVC)患者和突变阳性健康家族成员的心外膜传导异常——应用心电图成像技术的研究。
PLoS One. 2023 Jan 5;18(1):e0280111. doi: 10.1371/journal.pone.0280111. eCollection 2023.
7
Exercise-induced arrhythmogenic right ventricular cardiomyopathy: Reverse remodeling with detraining.运动诱发的致心律失常性右室心肌病:停训后的逆向重塑。
HeartRhythm Case Rep. 2022 Jun 17;8(9):599-603. doi: 10.1016/j.hrcr.2022.06.003. eCollection 2022 Sep.
8
Clinical significance of structural remodeling concerning substrate characteristics and outcomes in arrhythmogenic right ventricular cardiomyopathy.致心律失常性右室心肌病中结构重塑与底物特征及结局的临床意义
Heart Rhythm O2. 2022 May 5;3(4):422-429. doi: 10.1016/j.hroo.2022.04.007. eCollection 2022 Aug.
9
Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator.心律失常性右室心肌病的心律失常风险预测:心律失常性右室心肌病风险计算器的外部验证。
Eur Heart J. 2022 Aug 21;43(32):3041-3052. doi: 10.1093/eurheartj/ehac289.
10
Running the Risk: Exercise and Arrhythmogenic Cardiomyopathy.冒险:运动与致心律失常性心肌病
Curr Treat Options Cardiovasc Med. 2021 Oct;23(10). doi: 10.1007/s11936-021-00943-0. Epub 2021 Sep 18.